The mechanisms and roles of mitochondria dysfunction in cardiac arrhythmogenesis
线粒体功能障碍在心律失常发生中的机制和作用
基本信息
- 批准号:10734432
- 负责人:
- 金额:$ 73.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdenovirus VectorAffectAgingAnimalsAntioxidantsArrhythmiaAttenuatedBiochemicalBioenergeticsBioprobeBiosensorCOX7A2L geneCalciumCalcium SignalingCalpainCardiacCardiovascular DiseasesCardiovascular systemCatecholaminergic Polymorphic Ventricular TachycardiaCouplingCrista ampullarisDiameterDown-RegulationElectrocardiogramElectron TransportElementsEventExtravasationFemaleGenerationsGeneticHeartHeart DiseasesHeart HypertrophyHeart failureHeritabilityHomeostasisHumanHyperactivityHypertrophyInheritedInterruptionLeadLinkMalignant - descriptorMapsMediatingMembrane PotentialsMetabolicMitochondriaMitochondrial MatrixModelingModificationMolecularMolecular TargetMonitorMuscle CellsOPA1 geneOpticsOutcomeOutputPathologicPeptide HydrolasesPhysiologicalPilot ProjectsPlayPremenopauseProcessProductionProteinsProteolysisRattusReactive Oxygen SpeciesRespirationRiskRoleRyanodine Receptor Calcium Release ChannelSex DifferencesSignal TransductionStressStructural ProteinStructureSyndromeTachyarrhythmiasTestingTherapeuticThoracic aortaTissuesTransmission Electron MicroscopyVentricularVentricular ArrhythmiaVisualizationWorkloadcalpain inhibitorcalpastatinfluorescence lifetime imaginggain of functionheart functionimprovedin vivoinsightloss of functionmalemitochondrial dysfunctionmitochondrial membranemortalitynovelnovel strategiesoxidationreceptor functionresponserestorationsexsexual dimorphismsudden cardiac deathtargeted treatmentvector
项目摘要
Sudden cardiac death due to stress-induced ventricular tachyarrhythmias remains the major cause of mortality
in the world. Mitochondrial metabolic output in ventricular myocytes (VMs) is tightly linked to intracellular Ca2+
cycling in a process called excitation-contraction-bioenergetics (ECB) coupling. Disturbances in this process
contribute to arrhythmias not only in acquired conditions such as heart failure (HF), hypertrophy or aging, but in
heritable arrhythmia syndromes as well. During catecholaminergic surge, i.e. stress and maximum workload,
an increase in intracellular Ca2+ transient amplitude results in increased matrix [Ca2+] influx and accelerated
ATP production to meet increased metabolic demand. However, it comes with the risk of increased generation
of reactive oxygen species (ROS) by the electron transport chain (ETC). This can overcome antioxidant
defenses and adversely affect Ca2+ handling machinery and the ryanodine receptor (RyR2), promoting Ca2+
dependent arrhythmia. Therefore, the main objective of current proposal is the identification of new approaches
to maintain mitochondrial ROS and Ca2+homeostasis to improve cardiac function and reduce arrhythmic risk in
diseased hearts. In the course of preliminary studies, we discovered that a reduction in the formation of
quaternary supercomplexes from the elements of ETC plays a key role in accelerated mito-ROS production in
VMs from hypertrophic rat hearts and hearts from genetic rat model of catecholaminergic polymorphic
ventricular tachycardia (CPVT). Pilot studies revealed that changes in expression levels of two proteins can
underlie less compact ETC organization, namely (1) COX7RP, a key regulator of supercomplex formation, and
(2) structural protein OPA1 which controls mitochondria cristae diameter. Importantly, we discovered that
expression levels of both these proteins are higher in healthy females vs males, suggesting fundamental
differences in ECB coupling between sexes. Accordingly, two specific aims are proposed. Aim 1: To
determine the role and mechanisms of RyR2 hyperactivity-mediated changes in mitochondria function.
We created a unique gain-of RyR2 function rat model of CPVT to test the hypothesis that RyR2 hyperactivity
contributes to activation of Ca2+-dependent protease calpain residing in mitochondria intermembrane space
leading to OPA1 proteolysis. Aim 2: To determine the mechanisms and physiological significance of
COX7RP-dependent mitochondrial dysfunction in cardiac arrhythmias linked to RyR2 hyperactivity. We
hypothesize that COX7RP downregulation is the key contributor to the deficient mitochondria electron transport
and increased mito-ROS emission in cardiac hypertrophy and failure exacerbating pro-arrhythmic Ca2+i
mishandling.
由于应激诱发的室性快速性心律失常引起的心源性猝死仍然是死亡的主要原因
世界上心室肌细胞(VM)中线粒体代谢输出与细胞内Ca 2+紧密相关
在一个称为兴奋-收缩-生物能量学(ECB)耦合的过程中循环。在这个过程中的干扰
不仅在获得性疾病如心力衰竭(HF)、肥大或衰老中,
遗传性心律失常综合征。在儿茶酚胺能激增期间,即应激和最大工作负荷期间,
细胞内Ca 2+瞬时振幅的增加导致基质[Ca 2 +]内流增加,
生产ATP以满足增加的代谢需求。然而,这也带来了发电量增加的风险。
活性氧(ROS)通过电子传递链(ETC)。这可以克服抗氧化剂
防御和不利地影响Ca 2+处理机制和ryanodine受体(RyR 2),促进Ca 2 +
依赖性心律失常因此,本提案的主要目标是确定新的办法
维持线粒体活性氧和钙离子稳态,改善心脏功能并降低心律失常风险
病态的心脏在初步研究过程中,我们发现,
来自ETC元素的四元超复合物在加速线粒体-ROS产生中起关键作用,
来自肥大大鼠心脏的VM和来自儿茶酚胺能多态性遗传大鼠模型的心脏
室性心动过速(CPVT)。初步研究表明,两种蛋白质表达水平的变化可以
作为不太紧凑的ETC组织的基础,即(1)COX 7 RP,超复合物形成的关键调节剂,和
(2)控制线粒体嵴直径的结构蛋白OPA 1。重要的是,我们发现,
这两种蛋白质的表达水平在健康女性中高于男性,这表明
两性间ECB偶联的差异。因此,提出了两个具体目标。目标1:
确定RyR 2高活性介导的线粒体功能变化的作用和机制。
我们建立了一种独特的CPVT大鼠模型,以测试RyR 2过度活跃的假设,
有助于激活位于线粒体膜间隙的钙依赖性蛋白酶钙蛋白酶
导致OPA 1蛋白水解。目的2:探讨高脂血症的发生机制及其生理意义。
心律失常中的COX 7 RP依赖性线粒体功能障碍与RyR 2过度活跃有关我们
假设COX 7 RP下调是线粒体电子传递缺陷关键因素
心肌肥厚和心力衰竭时线粒体活性氧释放增加,
处理不当
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dmitry A Terentyev其他文献
Dmitry A Terentyev的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dmitry A Terentyev', 18)}}的其他基金
Defining the role of KCNN1 in atrial arrhythmias
定义 KCNN1 在房性心律失常中的作用
- 批准号:
10666164 - 财政年份:2023
- 资助金额:
$ 73.01万 - 项目类别:
Novel Mechanisms of Regulation of SK channels: Implications for Cardiac Arrhythmia
SK 通道调节的新机制:对心律失常的影响
- 批准号:
10161846 - 财政年份:2019
- 资助金额:
$ 73.01万 - 项目类别:
Novel Mechanisms of Regulation of SK channels: Implications for Cardiac Arrhythmia
SK 通道调节的新机制:对心律失常的影响
- 批准号:
10424495 - 财政年份:2019
- 资助金额:
$ 73.01万 - 项目类别:
Regulation of Calcium Homeostasis by MyomiRs in Heart Failure
心力衰竭中 MyomiRs 对钙稳态的调节
- 批准号:
8962163 - 财政年份:2014
- 资助金额:
$ 73.01万 - 项目类别:
Regulation of Calcium Homeostasis by MyomiRs in Heart Failure
心力衰竭中 MyomiRs 对钙稳态的调节
- 批准号:
9172660 - 财政年份:2014
- 资助金额:
$ 73.01万 - 项目类别:
相似海外基金
Clinical application of boron-conjugated adenovirus vector for neutron capture therapy
硼缀合腺病毒载体中子捕获治疗的临床应用
- 批准号:
19K09482 - 财政年份:2019
- 资助金额:
$ 73.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Vascular-targeted gene therapy to block proliferation of smooth muscle cells using a novel adenovirus vector
使用新型腺病毒载体进行血管靶向基因治疗以阻止平滑肌细胞增殖
- 批准号:
2273599 - 财政年份:2019
- 资助金额:
$ 73.01万 - 项目类别:
Studentship
Gene therapy for diabetes mellitus based on the suppression of lipotoxicity using an improved adenovirus vector
使用改进的腺病毒载体抑制脂毒性的糖尿病基因治疗
- 批准号:
18K14964 - 财政年份:2018
- 资助金额:
$ 73.01万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanisms of induction of mucosal immunity by adenovirus vector vaccine
腺病毒载体疫苗诱导粘膜免疫的机制
- 批准号:
16K18873 - 财政年份:2016
- 资助金额:
$ 73.01万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Hemophilia B Gene Therapy via CRISPR/Cas9-Targeted Integration of the Factor IX Gene using Adenovirus Vector Delivery
使用腺病毒载体递送通过 CRISPR/Cas9 靶向整合因子 IX 基因进行 B 型血友病基因治疗
- 批准号:
9193681 - 财政年份:2016
- 资助金额:
$ 73.01万 - 项目类别:
Gene therapy for diabetes mellitus and gene function analysis using a novel adenovirus vector
使用新型腺病毒载体进行糖尿病基因治疗和基因功能分析
- 批准号:
15K18939 - 财政年份:2015
- 资助金额:
$ 73.01万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Innate immue response through glycolipids by adenovirus-vector
腺病毒载体通过糖脂产生先天免疫反应
- 批准号:
26450450 - 财政年份:2014
- 资助金额:
$ 73.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of targeting adenovirus vector as boron carrier for boron neutron capture therapy
开发靶向腺病毒载体作为硼中子捕获疗法的硼载体
- 批准号:
26462183 - 财政年份:2014
- 资助金额:
$ 73.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a novel method for highly efficient gene targeting by adenovirus vector on human naive pluripotent stem cells
开发一种通过腺病毒载体高效基因靶向人类幼稚多能干细胞的新方法
- 批准号:
26893253 - 财政年份:2014
- 资助金额:
$ 73.01万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Development of adenovirus vector lacking VA RNA genes for efficient microRNA expression
开发缺乏 VA RNA 基因的腺病毒载体以实现有效的 microRNA 表达
- 批准号:
24701021 - 财政年份:2012
- 资助金额:
$ 73.01万 - 项目类别:
Grant-in-Aid for Young Scientists (B)